Characterization of gana-1, a Caenorhabditis elegans gene encoding a single ortholog of vertebrate α-galactosidase and α-N-acetylgalactosaminidase

BMC Cell Biology

Volumn 6, Issue , 2005, Pages

  Hujová, Jana ^a   Sikora, Jakub ^a   Dobrovolný, Robert ^a   Poupětová, Helena ^a   Ledvinová, Jana ^a   Kostrouchová, Marta ^a   Hřebíček, Martin ^a  

^a Charles University in Prague and General University Hospital in Prague   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; ALPHA N ACETYLGALACTOSAMINIDASE; AMMONIUM CHLORIDE; CONCANAMYCIN A; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; N ACETYLGALACTOSAMINE; POLYCLONAL ANTIBODY;

ALKALINIZATION; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CAENORHABDITIS ELEGANS; CELL PH; CELL VACUOLE; CHICKEN; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENE REPRESSION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC CODE; GENETIC DATABASE; HOMOGENATE; HUMAN; HUMAN VERSUS NONHUMAN DATA; IMMUNOFLUORESCENCE TEST; INTESTINE CELL; LABORATORY; LYSOSOME; MIXED CELL CULTURE; MOLECULAR CLONING; MOLECULAR EVOLUTION; MOLECULAR MODEL; MUSCLE CELL; NONHUMAN; ORTHOLOGY; PHYLOGENY; PROMOTER REGION; PROTEIN EXPRESSION; RICE; RNA INTERFERENCE; SEQUENCE HOMOLOGY; SIGNAL DETECTION; THREE DIMENSIONAL IMAGING; TRANSGENE; VERTEBRATE;

ANIMALIA; CAENORHABDITIS ELEGANS; VERTEBRATA;

EID: 25444525460     PISSN: 14712121     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2121-6-5     Document Type: Article

References (57)

1. Desnick RJ, Schindler D: α-N-Acetylgalactosaminidase Deficiency: Schindler Disease. In The Metabolic & Molecular Bases of Inherited Disease Volume 3. 8th edition. Edited by: Scriver CR, Beaudet AL, Sly WS and Valle D. New York, McGraw-Hill Companies, Inc.; 2001:3483-3506.
2. Desnick RJ, Ioannou YA, Eng CM: α-Galactosidase A Deficiency: Fabry Disease. In The Metabolic & Molecular Bases of Inherited Disease Volume 3. 8th edition. Edited by: Scriver CR, Beaudet AL, Sly WS and Valle D. New York, McGraw-Hill Companies, Inc.; 2001:3733-3774.
3. Dean KJ, Sung SS, Sweeley CC: The identification of alpha-galactosidase B from human liver as an alpha-N-acetylgalactosaminidase. Biochem Biophys Res Commun 1977, 77:1411-1417.
4. Schram AW, Hamers MN, Brouwer-Kelder B, Donker-Koopman WE, Tager JM: Enzymological properties and immunological characterization of alpha-galactosidase isoenzymes from normal and Fabry human liver. Biochim Biophys Acta 1977, 482:125-137.
5. Wang AM, Desnick RJ: Structural organization and complete sequence of the human alpha-N-acetylgalactosaminidase gene: homology with the alpha-galactosidase A gene provides evidence for evolution from a common ancestral gene. Genomics 1991, 10:133-142.
6. Henrissat B, Davies G: Structural and sequence-based classification of glycoside hydrolases. Curr Opin Struct Biol 1997, 7:637-644.
7. Garman SC, Hannick L, Zhu A, Garboczi DN: The 1.9 A structure of alpha-N-acetylgalactosaminidase: molecular basis of glycosidase deficiency diseases. Structure (Camb) 2002, 10:425-434.
8. Garman SC, Garboczi DN: The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol 2004, 337:319-335.
9. Fujimoto Z, Kaneko S, Momma M, Kobayashi H, Mizuno H: Crystal structure of rice alpha-galactosidase complexed with D-galactose. J Biol Chem 2003, 278:20313-20318.
10. Asfaw B, Ledvinova J, Dobrovolny R, Bakker HD, Desnick RJ, van Diggelen OP, de Jong JG, Kanzaki T, Chabas A, Maire I, Conzelmann E, Schindler D: Defects in degradation of blood group A and B glycosphingolipids in Schindler and Fabry diseases. J Lipid Res 2002, 43:1096-1104.
11. Dean KJ, Sweeley CC: Studies on human liver alpha-galactosidases. II. Purification and enzymatic properties of alpha-galactosidase B (alpha-N-acetylgalactosaminidase). J Biol Chem 1979, 254:10001-10005.
12. Schram AW, Hamers MN, Tager JM: The identity of alpha-galactosidase B from liver. Adv Exp Med Biol 1978, 101:525-529.
13. Mayes JS, Scheerer JB, Sifers RN, Donaldson ML: Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease. Clin Chim Acta 1981, 112:247-251.
14. Genome sequence of the nematode C. elegans: a platform for investigating biology. The C. elegans Sequencing Consortium. Science 1998, 282:2012-2018.
15. Wormbase [http://www.wormbase.org/]
16. The C. elegans ORFeome cloning project [http://worfdb.dfci.harvard.edu/]
17. Krause M: Transcription and Translation. In Caenorhabditis elegans: Modern Biological Analysis of an Organism Volume 48. 1st edition. Edited by: Epstein HF and Shakes DC. San Diego, Academic Press, Inc.; 1995:483-512.
18. Nimmo R, Woollard A: Widespread organisation of C. elegans genes into operons: fact or function? Bioessays 2002, 24:983-987.
19. Blumenthal T, Gleason KS: Caenorhabditis elegans operons: form and function. Nat Rev Genet 2003, 4:112-120.
20. Blom D, Speijer D, Linthorst GE, Donker-Koopman WG, Strijland A, Aerts JM: Recombinant enzyme therapy for Fabry disease: absence of editing of human alpha-galactosidase A mRNA. Am J Hum Genet 2003, 72:23-31.
21. Nadeau JH, Sankoff D: Comparable rates of gene loss and functional divergence after genome duplications early in vertebrate evolution. Genetics 1997, 147:1259-1266.
22. Sarkis GJ, Kurpiewski MR, Ashcom JD, Jen-Jacobson L, Jacobson LA: Proteases of the nematode Caenorhabditis elegans. Arch Biochem Biophys 1988, 261:80-90.
23. Sebastiano M, D'Alessio M, Bazzicalupo P: Beta-glucuronidase mutants of the nematode Caenorhabditis elegans. Genetics 1986, 112:459-468.
24. Karageorgos LE, Isaac EL, Brooks DA, Ravenscroft EM, Davey R, Hopwood JJ, Meikle PJ: Lysosomal biogenesis in lysosomal storage disorders. Exp Cell Res 1997, 234:85-97.
25. Conzelmann E, Sandhoff K: Glycolipid and glycoprotein degradation. Adv Enzymol Relat Areas Mol Biol 1987, 60:89-216.
26. Kamath RS, Martinez-Campos M, Zipperlen P, Fraser AG, Ahringer J: Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol 2000, 2:.
27. Kostich M, Fire A, Fambrough DM: Identification and molecular-genetic characterization of a LAMP/CD68-like protein from Caenorhabditis elegans. J Cell Sci 2000, 113:2595-2606.
28. Fares H, Greenwald I: Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog. Nat Genet 2001, 28:64-68.
29. Kneen M, Farinas J, Li Y, Verkman AS: Green fluorescent protein as a noninvasive intracellular pH indicator. Biophys J 1998, 74:1591-1599.
30. Mello C, Fire A: DNA transformation. In Caenorhabditis elegans: Modern Biological Analysis of an Organism Volume 48. 1st edition. Edited by: Epstein HF and Shakes DC. San Diego, Academic Press; 1995:451-481.
31. Stinchcomb DT, Shaw JE, Carr SH, Hirsh D: Extrachromosomal DNA transformation of Caenorhabditis elegans. Mol Cell Biol 1985, 5:3484-3496.
32. Clokey GV, Jacobson LA: The autofluorescent "lipofuscin granules" in the intestinal cells of Caenorhabditis elegans are secondary lysosomes. Mech Ageing Dev 1986, 35:79-94.
33. Poole B, Ohkuma S: Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J Cell Biol 1981, 90:665-669.
34. Demaurex N: pH Homeostasis of cellular organelles. News Physiol Sci 2002, 17:1-5.
35. Brenner S: The genetics of Caenorhabditis elegans. Genetics 1974, 77:71-94.
36. Mello CC, Kramer JM, Stinchcomb D, Ambros V: Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. Embo J 1991, 10:3959-3970.
37. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
38. WormBase Release WS100 [http://ws100.wormbase.org]
39. WormBase Release WS110 [http://ws110.wormbase.org]
40. Wormbase BLAST or BLAT Search [http://www.wormbase.org/db/searches/blat]
41. GenBank [http://www.ncbi.nlm.nih.gov/Genbank/index.html]
42. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
43. Protein families database of alignments and HMMs [http://www.sanger.ac.uk/Software/Pfam]
44. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
45. Swiss-Prot / TrEMBL database [http://www.expasy.org/sprot/]
46. Felsenstein J: PHYLIP - Phylogeny Inference Package (Version 3.2). Cladistics 1988, 5:164-166.
47. Felsenstein J: Confidence-Limits on Phylogenies - an Approach Using the Bootstrap. Evolution 1985, 39:783-791.
48. Needleman SB, Wunsch CD: A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol 1970, 48:443-453.
49. Rice P, Longden I, Bleasby A: EMBOSS: The European molecular biology open software suite. Trends in Genetics 2000, 16:276-277.
50. Bendtsen JD, Nielsen H, von Heijne G, Brunak S: Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004, 340:783-795.
51. PDB - Protein Data Bank [http://www.rcsb.org/pdb/]
52. Guex N, Peitsch MC: SWISS-MODEL and the Swiss-Pdb-Viewer: an environment for comparative protein modeling. Electrophoresis 1997, 18:2714-2723.
53. PovRay software [http://www.povray.org/]
54. Nonet ML, Grundahl K, Meyer BJ, Rand JB: Synaptic function is impaired but not eliminated in C. elegans mutants lacking synaptotagmin. Cell 1993, 73:1291-1305.
55. Hartree EF: Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 1972, 48:422-427.
56. Gallagher S, Winston SE, Fuller SA, Hurrell JGR: Analysis of Proteins. In Current Protocols in Molecular Biology Volume 2. 1st edition. Edited by: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K. Hoboken, John Wiley & Sons, Inc.; 1997:10.8.
57. Wenger DA, Williams C: Screening for Lysosomal Disorders. In Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual 1st edition. Edited by: Hommes FA. New York, Wiley-Liss, Inc.; 1991:587-617.